Kolexia
Dulery Remy
Hématologie
Hôpital Saint-Antoine
Paris, France
583 Activités
2.4 K Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Maladie du greffon contre l'hôte Leucémies Maladie de Hodgkin Leucémie aigüe myéloïde Tumeurs hématologiques COVID-19 Lymphome B Leucémie myéloïde

Industries

Novartis
6 collaboration(s)
Dernière en 2022
Takeda Pharmaceutical
6 collaboration(s)
Dernière en 2023
Gilead
4 collaboration(s)
Dernière en 2022
Servier
2 collaboration(s)
Dernière en 2023

Dernières activités

Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)
Essai Clinique (Roche)   13 mars 2024
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial.
Blood cancer journal   19 février 2024
Bi- and Tri-specific antibodies in non-Hodgkin lymphoma: current data and perspectives.
Blood cancer journal   25 janvier 2024
Lymphomes | GCO
Youtube @ Société Française de Cardiologie   01 décembre 2023
Opportunistic Infections in Patients Receiving Post-Transplant Cyclophosphamide: Impact of Haploidentical Versus Unrelated Donor Allograft.
Transplantation and cellular therapy   18 novembre 2023
Comparison of Two Reduced Intensity Conditioning Regimens (Baltimore with Clofarabine vs Thiotepa-Busulfan-Fludarabine) in Adults Receiving Peripheral Blood Stem Cell Haploidentical Transplantation for Myeloid Malignancies: A Retrospective Study of the SFGM-TC
65th ASH Annual Meeting Abstracts   02 novembre 2023
Invasive Fungal Infections after CAR T-Cell Therapy for B-Cell Lymphoma: A Study from the French Descart Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Allogeneic Hematopoietic Cell Transplantation in the Elderly Results in Similar Survival with Matched Related or Unrelated and Haploidentical Donors: A Report from the Société Francophone De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)
65th ASH Annual Meeting Abstracts   02 novembre 2023
Real World Data of Axicabtagene Ciloleucel As Second Line Therapy for Patients with Large B Cell Lymphoma: First Results of a Lysa Study from the French Descar-T Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Nature medicine   31 octobre 2023